Evan David Seigerman
Stock Analyst at BMO Capital
(0.87)
# 2232
Out of 5,368 analysts
51
Total ratings
30.00%
Success rate
7.35%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NGNE Neurogene | Maintains: Outperform | 22 26 | 19.77 | 31.51% | 2 | Jun 12, 2025 | |
REGN Regeneron Pharmaceut... | Maintains: Outperform | 800 600 | 529.27 | 13.36% | 7 | Jun 2, 2025 | |
MRUS Merus | Maintains: Outperform | 96 110 | 54.65 | 101.28% | 1 | May 23, 2025 | |
ACAD ACADIA Pharmaceutica... | Maintains: Outperform | 24 28 | 21.68 | 29.15% | 1 | May 19, 2025 | |
ARVN Arvinas | Maintains: Outperform | 20 10 | 7.38 | 35.5% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 105 64 | 79.89 | -19.89% | 6 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 105 96 | 81.72 | 17.47% | 4 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 208 215 | 190.93 | 12.61% | 7 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 362 346 | 295.15 | 17.23% | 4 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 27 | 9.78 | 176.07% | 3 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 52 57 | n/a | n/a | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 83 100 | 21.7 | 360.83% | 2 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 33 36 | 24.52 | 46.82% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 31 72 | n/a | n/a | 4 | Oct 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 3 | 5.13 | -41.52% | 1 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 369 396 | 819.67 | -51.69% | 1 | Sep 6, 2022 |